Switching from Premixed Insulin to Insulin Glargine in Type 2 Diabetes
Author Information
Author(s): Harm Hammer, Andreas Klinge
Primary Institution: Facharzt für Innere Medizin, Hausärztliche Versorgung Bremen, Germany
Hypothesis
Is switching from premixed insulin to insulin glargine plus oral antidiabetic agents effective for glycaemic control in type 2 diabetes patients?
Conclusion
Switching to insulin glargine plus oral antidiabetic agents significantly improves fasting blood glucose and HbA1c in type 2 diabetes patients inadequately controlled with premixed insulin.
Supporting Evidence
- Fasting blood glucose improved from 9.9 to 6.9 mmol/l after 12 weeks.
- HbA1c levels decreased from 8.3% to 7.2% during the study.
- 48.9% of patients achieved fasting blood glucose levels below 6.7 mmol/l after treatment.
- Significant weight loss was observed, averaging -1.5 kg over the study period.
- 71 adverse events were reported, with hypoglycaemia being the most common.
Takeaway
This study shows that if your diabetes isn't well controlled with a certain type of insulin, switching to a different kind can help you manage your blood sugar better.
Methodology
This was a 12-week observational study where patients switched from premixed insulin to insulin glargine plus oral antidiabetic agents, with blood glucose levels measured at the start and end of the study.
Potential Biases
Potential bias due to the non-randomized nature of the study and reliance on physician and patient reporting.
Limitations
The study was observational and lacked a control group, which may affect the interpretation of the results.
Participant Demographics
Patients were predominantly from Germany, with a median age of 63.2 years, and 49.7% were male.
Statistical Information
P-Value
p ≤ 0.001
Statistical Significance
p ≤ 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website